Share and Cite
Stauffer, P.E.; Brinkley, J.; Jacobson, D.A.; Quaranta, V.; Tyson, D.R. Purinergic Ca2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma. Cancers 2024, 16, 2426. https://doi.org/10.3390/cancers16132426
Stauffer PE, Brinkley J, Jacobson DA, Quaranta V, Tyson DR. Purinergic Ca2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma. Cancers. 2024; 16(13):2426. https://doi.org/10.3390/cancers16132426
Chicago/Turabian StyleStauffer, Philip E., Jordon Brinkley, David A. Jacobson, Vito Quaranta, and Darren R. Tyson. 2024. "Purinergic Ca2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma" Cancers 16, no. 13: 2426. https://doi.org/10.3390/cancers16132426